Differential involvement of PU.1 and Id2 downstream of TGF-β1 during Langerhans-cell commitment

被引:52
作者
Heinz, LX [1 ]
Platzer, B [1 ]
Reisner, PM [1 ]
Jörgl, A [1 ]
Taschner, S [1 ]
Göbel, F [1 ]
Strobl, H [1 ]
机构
[1] Med Univ Vienna, Inst Immunol, A-1090 Vienna, Austria
关键词
D O I
10.1182/blood-2005-04-1721
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Langerhans cells (LCs) are highly abundant dendritic cells (DCs) in epidermal and mucosal tissues. The transcription factors PU.1 and Id2 have been implicated as positive regulators of LC development from hematopoietic progenitor cells. LC differentiation from progenitors is absolutely dependent on transforming growth factor beta 1 JGF-beta 1 in vitro as well as in vivo; however, downstream mechanisms are poorly defined. We found that both PU.1 and Id2 are induced by TGF-P1 in human CD34(+) monocyte/LC (M/LC) progenitor cells, and that neither ectopic PU.1 or Id2 alone, nor both together, could replace TGF-P1 in its instructive function on LC commitment. However, both factors critically contributed to LC differentiation by acting at 2 distinct intersection points. Ectopic PU.1 strongly enhanced TGF-beta 1-dependent LC development. Additionally, Notch-induced generation of interstitial-type DCs was associated with PU.1 up-regulation. Thus, PU.1 is generally increased during myeloid DC development. Ectopic Id2 inhibits the acquisition of early monocytic characteristics by cells generated in the absence of TGF-beta 1 and also inhibits monocyte induction by alternative stimuli. Since TGF-P1 represses a default monocyte pathway of common progenitor cells, PU.1 and Id2 seem to modulate lineage options of M/LC precursors, downstream of TGF-beta 1.
引用
收藏
页码:1445 / 1453
页数:9
相关论文
共 53 条
[1]
Myeloid development is selectively disrupted in PU.1 null mice [J].
Anderson, KL ;
Smith, KA ;
Conners, K ;
McKercher, SR ;
Maki, RA ;
Torbett, BE .
BLOOD, 1998, 91 (10) :3702-3710
[2]
Transcription factor PU.1 is necessary for development of thymic and myeloid progenitor-derived dendritic cells [J].
Anderson, KL ;
Perkin, H ;
Surh, CD ;
Venturini, S ;
Maki, RA ;
Torbett, BE .
JOURNAL OF IMMUNOLOGY, 2000, 164 (04) :1855-1861
[3]
Balance of MafB and PU.1 specifies alternative macrophage or dendritic cell fate [J].
Bakri, Y ;
Sarrazin, S ;
Mayer, UP ;
Tillmanns, S ;
Nerlov, C ;
Boned, A ;
Sieweke, MH .
BLOOD, 2005, 105 (07) :2707-2716
[4]
Immunobiology of dendritic cells [J].
Banchereau, J ;
Briere, F ;
Caux, C ;
Davoust, J ;
Lebecque, S ;
Liu, YT ;
Pulendran, B ;
Palucka, K .
ANNUAL REVIEW OF IMMUNOLOGY, 2000, 18 :767-+
[5]
BelloFernandez C, 1997, EXP HEMATOL, V25, P1158
[6]
Bergh G, 1999, BLOOD, V94, P1971
[7]
A role for TGF beta 1 in Langerhans cell biology - Further characterization of the epidermal Langerhans cell defect in TGF beta 1 null mice [J].
Borkowski, TA ;
Letterio, JJ ;
Mackall, CL ;
Saitoh, A ;
Wang, XJ ;
Roop, DR ;
Gress, RE ;
Udey, MC .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (03) :575-581
[8]
A role for endogenous transforming growth factor beta 1 in Langerhans cell biology: The skin of transforming growth factor beta 1 null mice is devoid of epidermal Langerhans cells [J].
Borkowski, TA ;
Letterio, JJ ;
Farr, AG ;
Udey, MC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (06) :2417-2422
[9]
Respective involvement of TGF-β and IL-4 in the development of Langerhans cells and non-Langerhans dendritic cells from CD34+ progenitors [J].
Caux, C ;
Massacrier, C ;
Dubois, B ;
Valladeau, J ;
Dezutter-Dambuyant, C ;
Durand, I ;
Schmitt, D ;
Saeland, S .
JOURNAL OF LEUKOCYTE BIOLOGY, 1999, 66 (05) :781-791
[10]
CD34(+) hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha [J].
Caux, C ;
Vanbervliet, B ;
Massacrier, C ;
DezutterDambuyant, C ;
deSaintVis, B ;
Jacquet, C ;
Yoneda, K ;
Imamura, S ;
Schmitt, D ;
Banchereau, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (02) :695-706